权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

ADVANCING GENE-EDITING NUCLEASES FOR DIVERSE ZEBRAFISH APPLICATIONS

推进基因编辑核酸酶在多种斑马鱼中的应用

基本信息

批准号：
10737505
负责人：
RANDALL T PETERSON
金额：
$ 49.28万
依托单位：
UNIVERSITY OF UTAH
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-09-20 至 2027-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10737505
关键词：
Address Animals Area Bar Codes Biomedical Research Biomedical Technology CRISPR screen CRISPR/Cas technology Cells Clustered Regularly Interspaced Short Palindromic Repeats Collaborations Collection Communities DNA Development Disease model Embryo Engineering Financial Support Fishes Funding Future Gene Transfer Techniques Genes Genetic Diseases Genome Genomics Integrase Location Locomotion Methods Microfluidics Modification Molecular Monitor Morphology Mutation Needles Organism Phenotype Plasmids Proteins Recovery Regulator Genes Regulatory Element Research Personnel Site Specific qualifier value Specificity System Technology Transgenic Organisms Visual Zebrafish cell type combinatorial gene function genome editing genomic locus high throughput screening high throughput technology innovation interest metabolomics molecular phenotype mutant nanolitre new technology nuclease prime editing promoter recombinase reverse genetics screening single-cell RNA sequencing small molecule technology development technology platform tool transcription activator-like effector nucleases

项目摘要

Summary CRISPR-Cas9 and related technologies have dramatically transformed our ability to manipulate the genomes of countless organisms, generate disease models, rapidly discover the functions of genes, and create new treatments for genetic disorders. Nevertheless, the full potential of the field has yet to be realized. Over the past fifteen years, the Peterson and Yeh labs have collaborated in the development of genome editing tools and have contributed to several key advances, including the first use of CRISPR-Cas9 to modify the genome of any animal, the first use of prime editing in zebrafish, and the first technology for high- throughput CRISPR screening in a vertebrate. During the current funding period, we have successfully completed all three of our aims and produced new technologies, TICIT and MIC-Drop, that raise exciting new opportunities for further development and application. In this competitive renewal application, we propose to expand on TICIT and MIC-Drop, developing several useful new gene-editing approaches. Aim 1 builds upon Targeted Integration by CRISPR-Cas9 and Integrase Technologies (TICIT), which utilizes the site-specific DNA recombinase – phiC31 integrase – to insert DNA into genomic target sites that have been pre-specified by CRISPR-Cas9 modification. Unlike traditional transgenic methods which lead to random genome insertion, TICIT enables precise integration of plasmids into the genome at prespecified loci, avoiding inadvertent gene disruption and positional effects. Building upon TICIT, we propose now to expand the utility of integrases for site-specific genome editing. In the renewal application, we propose new technologies to make TICIT more efficient and permit combinatorial uses of multiple integrases in various safe- harbor genomic loci. Additionally, we will use the optimized TICIT platform to develop high-throughput screening systems for isolating synthetic promoters with enhanced cell-state or cell-type specificity. Aim 2 builds upon Multiplexed, Intermixed CRISPR Droplets (MIC-Drop), which combines multiplexed CRISPR sgRNAs, Cas9 protein, and DNA barcodes into nanoliter-volume microfluidic droplets that can then be injected from a single needle into thousands of zebrafish. MIC-Drop enables rapid and efficient disruption of hundreds or thousands of genes, and after identification of phenotypes of interest, the causative gene can be quickly identified by barcode recovery. Building upon MIC-Drop, we propose now to expand the utility of MIC-Drop for molecular phenotyping. Previously, we have used visual inspection to identify zebrafish mutants with interesting phenotypes, followed by PCR-based recovery of the DNA barcodes. We now plan to combine MIC-Drop technology with powerful molecular phenotyping tools, such as single-cell RNA sequencing (scRNAseq) and metabolomics. In this aim, we will develop new methods, barcodes, and workflows that will enable efficient gene disruption and molecular phenotyping at unprecedented scales.

总结